Biocept (BIOC) Reports Q2 Loss of $0.22

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.22), versus ($0.67) reported last year. Revenue for the quarter came in at $76.77 million, versus $19.25 million reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• L3Harris CEO steps down amid conduct review, shares drop
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings